PEPTONIC Medical AB announced that the company has signed a license agreement with Swiss medical device company Prima Lab SA for the sale of self-tests for measurement of FSH hormone in Sweden. The agreement means that Peptonic gets the right to sell Prima Lab's self-test for FSH hormone under its own brand VagiVital® in Sweden, with a planned launch in early 2024. Prima Lab is a Swiss medical technology company with a specific focus on self-tests for women's health.

The company has its own development and sells its products in more than thirty countries around the world. During menopause, elevated FSH values are common, which is why a test that measures this is a good indicator. Prima Lab is already a strategic partner to Peptonic as it sells Peptonic’s patented test for amniocentesis in a number of selected markets in Europe and out-license a urinary tract infection test that will be launched at the end of the year on the Swedish market by Peptonic.